P

Prestige Consumer Healthcare
D

PBH

83.640
USD
-0.04
(-0.05%)
Market Closed
Volume
11,100
EPS
5
Div Yield
-
P/E
19
Market Cap
4,133,046,093
Related Instruments
BAX
BAX
-0.130
(-0.43%)
29.800 USD
BDX
BDX
-1.320
(-0.78%)
168.650 USD
CAH
CAH
0.470
(0.29%)
165.350 USD
DGX
DGX
0.790
(0.44%)
179.760 USD
H
HSIC
0.980
(1.40%)
71.150 USD
MCK
MCK
4.85
(0.67%)
729.16 USD
MDT
MDT
-0.485
(-0.56%)
85.725 USD
P
PRGO
0.060
(0.23%)
26.330 USD
SYK
SYK
-0.03
(-0.01%)
373.28 USD
More
News

Title: Prestige Consumer Healthcare

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.